で公開中です! 詳しく見る
INSPのアイコン

Inspire Medical Systems

68.79 USD
-1.33
1.9%
終値時点 更新済み 10月16日 16:00 EDT
1日
-1.9%
5日間
-1.71%
1か月
-5.44%
3か月
33.47%
6か月
21.86%
年初来
-25.45%
1年
-11.06%
5年間
-72.24%
10年間
175.38%
 

概要: Inspire Medical Systems Inc operates as a medical technology company. It focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA). It offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea. The firm has operating footprints in the United States and All other countries wherein, it generates a majority of its revenue from the United States. Its segment revenues are derived from the sales of its product, the Inspire system, to hospitals and ambulatory surgery centers in the U.S. and in selected countries in Europe and the Asia Pacific region.

従業員数: 1,333

ニュース

ポジティブ
ニュートラル
ネガティブ
センチメント 3か月間
ポジティブ 50%
ニュートラル 42.3%
ネガティブ 7.7%
ニュートラル
GlobeNewsWire
11 日前
Inspire Medical Systems, Inc. to Report Third Quarter 2026 Financial Results on November 2, 2026
MINNEAPOLIS, Oct. 05, 2026 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire) will release financial results for the third quarter 2026 after the close of trading on Monday, November 2. Inspire's management team will host a corresponding conference call beginning at 5:00 p.m. Eastern Time to discuss the financial results and recent business developments.
Inspire Medical Systems, Inc. to Report Third Quarter 2026 Financial Results on November 2, 2026
ポジティブ
Zacks Investment Research
11 日前
Inspire Medical Gains New CPT Codes for Hypoglossal Nerve Stimulation
INSP gains new Category I CPT codes for Inspire V procedures, creating a dedicated coding framework effective Jan. 1, 2028.
Inspire Medical Gains New CPT Codes for Hypoglossal Nerve Stimulation
ニュートラル
GlobeNewsWire
15 日前
Inspire Medical Systems, Inc. Announces Approval of New Hypoglossal Nerve Stimulation CPT® Codes by the AMA Editorial Panel
MINNEAPOLIS, Oct. 01, 2026 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea (OSA), today announced that the American Medical Association (AMA) CPT® Editorial Panel has approved the establishment of a new set of Current Procedural Terminology (CPT®) codes that accurately describe and include the Inspire V system. The new Category I codes are scheduled to take effect on January 1, 2028.
Inspire Medical Systems, Inc. Announces Approval of New Hypoglossal Nerve Stimulation CPT® Codes by the AMA Editorial Panel
ポジティブ
Zacks Investment Research
23 日前
Here's Why You Should Retain INSP Stock in Your Portfolio for Now
Inspire Medical is navigating a major product transition as clinical evidence, patient access efforts and reimbursement progress support growth prospects.
Here's Why You Should Retain INSP Stock in Your Portfolio for Now
ニュートラル
Zacks Investment Research
先月
Zacks Industry Outlook Medical Systems, American Well and Butterfly Network
Medical Systems, American Well and Butterfly Network have been highlighted in this Industry Outlook article.
Zacks Industry Outlook Medical Systems, American Well and Butterfly Network
ポジティブ
Zacks Investment Research
先月
3 Medical Info Systems Stocks to Gain From GenAI Boom Amid Cyber Risk
INSP, AMWL and BFLY are positioned to gain from digital health and AI demand despite cybersecurity risks.
3 Medical Info Systems Stocks to Gain From GenAI Boom Amid Cyber Risk
ネガティブ
Zacks Investment Research
先月
Why Is Inspire (INSP) Down 4.1% Since Last Earnings Report?
Inspire (INSP) reported earnings 30 days ago. What's next for the stock?
Why Is Inspire (INSP) Down 4.1% Since Last Earnings Report?
ニュートラル
GlobeNewsWire
先月
Inspire Medical Systems, Inc. to Present at the Wells Fargo 21st Annual Healthcare Conference
MINNEAPOLIS, Aug. 26, 2026 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea, announced today that its management team will present at the Wells Fargo 21st Annual Healthcare Conference on Wednesday, September 9, 2026.
Inspire Medical Systems, Inc. to Present at the Wells Fargo 21st Annual Healthcare Conference
ポジティブ
Zacks Investment Research
先月
INSP Stock Rallies Nearly 40% YTD: Can Its Growth Story Continue?
Inspire Medical stock's 39.7% three-month surge is driven by the easing of reimbursement pressures, increasing Inspire V adoption and Project Horizon targeting longer-term expansion.
INSP Stock Rallies Nearly 40% YTD: Can Its Growth Story Continue?
ニュートラル
Zacks Investment Research
先月
Here's Why You Should Add INSP Stock to Your Portfolio Now
Inspire Medical's Inspire V adoption, clinical evidence and underpenetrated OSA market support growth despite coding and reimbursement headwinds.
Here's Why You Should Add INSP Stock to Your Portfolio Now
価格チャートは Lightweight Charts™ を使用して実装されています